Extrathyroidal actions of antithyroid thionamides

Toxicology Letters

Volumn 128, Issue 1-3, 2002, Pages 117-127

  Bandyopadhyay, Uday ^a   Biswas, Kausik ^a   Banerjee, Ranajit K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Antithyroid thionamides; Blood cells and immune suppression; Flavin monooxygenase; Gastric secretions; Peroxidases; Prostaglandin synthase

Indexed keywords

ANTITHYROID AGENT; CATALASE; HISTAMINE H2 RECEPTOR; HYDROGEN PEROXIDE; LACTOPEROXIDASE; PEPSINOGEN; PEROXIDASE; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE DERIVATIVE; THIOUREA DERIVATIVE;

AGRANULOCYTOSIS; ANTIBACTERIAL ACTIVITY; APLASTIC ANEMIA; AUDITORY SYSTEM; BLOOD CELL; BOWMAN MEMBRANE; CELL DAMAGE; CELL FUNCTION; CELL STIMULATION; DISEASE SEVERITY; DRUG BINDING; DRUG MECHANISM; DRUG METABOLISM; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; EXOCRINE GLAND; EXOCRINE SECRETION; GENE EXPRESSION; HEARING LOSS; HEMATOLOGIC DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; NONHUMAN; OLFACTORY EPITHELIUM; OLFACTORY SYSTEM; PRIORITY JOURNAL; PURPURA; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; STOMACH ULCER; WOUND HEALING;

ANIMALS; ANTITHYROID AGENTS; ENZYME INHIBITORS; GASTRIC ACID; HEARING; IMMUNOSUPPRESSION; LACTOPEROXIDASE; METHIMAZOLE; MICE; OLFACTORY MUCOSA; PEROXIDASE; RATS; THIOAMIDES;

MAMMALIA; PURPURA;

EID: 0037051177     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00539-2     Document Type: Review

References (94)

1. Iodide peroxidase in rat thyroid and salivary glands and its inhibition by antithyroid compounds
2. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole
3. Further studies on the chemical nature of compounds which inhibit the function of the thyroid gland
4. Antithyroid arthritis syndrome
5. Localization of gastric peroxidase and its inhibition by mercaptomethylimidazole, an inducer of gastric acid secretion
6. Mechanism-based inactivation of gastric peroxidase by mercaptomethylimidazole
7. Irreversible inactivation of lactoperoxidase by mercaptomethylimidazole through generation of a thiyl radical: Its use as a probe to study the active site
8. Activation of parietal cell by mercaptomethylimidazole - A novel inducer of gastric acid secretion
9. Role of reactive oxygen species in mercaptomethylimidazole-induced gastric acid secretion and stress-induced gastric ulceration
10. Gastric peroxidase-localization, catalytic properties and possible role in extrathyroidal thyroid hormone formation
11. Gastric peroxidase and its role in cellular control of gastric acid secretion
12. Adverse effects of thyroid hormone preparations and antithyroid drugs
13. Effects of methimazole on renal function in cats with hyperthyroidism
14. Methimazole toxicity in rodents: Covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb
15. Histamine H2-receptor-mediated stimulation of gastric acid secretion by mercaptomethylimidazole
16. Dissociation of gastric acid and pepsinogen secretion in response to mercaptomethylimidazole - A new secretory compound
17. 2
18. Massive plasmocytosis due to methimazole-induced bone marrow toxicity
19. Metabolism-dependent toxicity of methimazole in the olfactory nasal mucosa
20. Lymphoproliferative activity of methimazole: Free SH group dependency
21. Methimazole inhibits peripheral lymphocyte proliferation by inducing S-quiescent phase arrest
22. Physiological factors affecting protein expression of flavin-containing monooxygenase 1, 2 and 5
23. Oxidation of caffeine to theobromine and theophyline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes
24. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease
25. Methimazole therapy in Graves' disease influences the abnormal expression of CD 69 (early activation antigen) on T cells
26. The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil and propylthiouracil in vitro and its relationship to in vitro finding
27. Thiocyanate, a plausible physiological electron donor of gastric peroxidase
28. Purification, characterization and origin of rat gastric peroxidase
29. Mechanism-based inhibition of lactoperoxidase by thiocarbamide goitrogens
30. Peroxidase catalyzed S-oxygenation: Mechanism of oxygen transfer for lactoperoxidase
31. Effect of orally administered antithyroid thiurelenes on PCNA and P53 expression in psoriatic lesions
32. Mechanism of inactivation of thyroid peroxidase by thiourelene drugs
33. Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease
34. Methimazole-induced severe aplastic anemia: Unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor
35. Evaluation of olfactory and auditory system effects of the antihyperthyroid drug carbimazole in the Long-Evans rat
36. Olfactory toxicity of methimazole: Dose-response and structure activity studies and characterization of flavin-containing monooxygenase activity in the Long-Evans rat olfactory mucosa
37. Characterization of olfactory deficits in the rat following administration of 2,6-dichlorobenzonitrile (dichlobenil), 3,3′iminodipropionitrile, or methimazole
38. Elevated CD 69 expression on native peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: Discordant effect of methimazole on HLA-DR and CD 69
39. Ga-67 imaging of thiamazole-induced agranulocytosis associated with multiple focal infections
40. Mechanism of action of antithyroid compounds
41. Cryofibrinogenemia with polyarthralgia, Raynaud's phenomenon and acral ulcer in a patient with Graves', disease treated with methimazole
42. Thyroid and antithyroid drugs
43. The enzymes of detoxification
44. Severe malformations in infant born to hyperthyroid woman on methimazole
45. A two component monooxygenase catalyzes both the hydroxylation of p-nitrophenol and the oxidative release of nitrite from 4-nitrocatechol in Bacillus sphaericus JS905
46. Pituitary GH and prolactin deficiency and testis enlargement in hypothyroid rats caused by goitrogen methimazole
47. Inactivation of estrogens by rat uterine preparations
48. Antiinflammatory action of methimazole
49. Metabolism of 14C-labelled 5-nitro-1,2,4-pyriazole-3-one by rat liver microsomes - Evidence for the participation of cytochrome P-450
50. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure
51. Methimazole and propylthiouracil increase thyroglobulin gene expression in FRTL-5-cells
52. Methimazole increases thyroid specific mRNA concentration in human thyroid cells and FRTL-5-cells
53. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelminthic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose regime
54. 14C] oestradiol by oestrogen-induced uterine peroxidase
55. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure
56. The effects of methimazole on haematopoiesis in mice
57. 35S-methimazole in the rat
58. Methimazole-induced aplastic anemia in third exposure: Successful treatment with recombinant human granulocyte colony stimulating factor
59. Iodide binding and regulation of lactoperoxidase activity toward thyroid goitrogens
60. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease
61. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris
62. Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: Structure toxicity and metabolic studies
63. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: Opposite effects of interferon and methimazole
64. Lactoperoxidase: Identification and isolation from harderian and lacrimal glands
65. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodide peroxidase
66. Reactions of ferryl lactoperoxidase (compound II) with sulfide and sulfhydryl compounds
67. 2, tyrosine, and methylmercaptoimidazole (goitrogen) in comparison with bovine lactoperoxidase
68. Methimazole slows hepatocyte streaming in rats
69. The mechanism for the inhibition of prostaglandin H synthase-catalyzed xenobiotic oxidation by methimazole. Reaction with free radical oxidation products
70. S-oxidation of thiourelenes catalyzed by a microsomal flavoprotein mixed function oxidase
71. Interaction of lactoperoxidase with thiols and diiodotyrosine
72. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease
73. Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system
74. Effect of antithyroid drugs on hydroxyl radical formation and alpha-1-proteinase inhibitor inactivation by neutrophils: Therapeutic implications
75. Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids
76. Methimazole-induced cholestatic liver injury, mimicking sclerosis cholangitis
77. Calcium, magnesium, and zinc status in experimental hypothyroidism
78. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids
79. Liver sulfoxidative metabolism of albendazole in rat: Enantioselectivity and effect of methimazole
80. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves' disease. A novel side effect of antithyroid drugs
81. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease
82. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia
83. Thyroid peroxidase and thyroxine biosynthesis
84. The mechanism of action of the thiourelene antithyroid drugs
85. Myeloperoxidase-catalyzed iodination and coupling
86. Interaction of specific and innate factors of immunity: IgA enhances the antimicrobial effect of the lactoperoxidase system against streptococcus mutans
87. Intermittent polyarthritis due to propylthiouracil
88. Aplasia cutis congenita after exposure to methimazole: A causal relationship?
89. Mechanistic analysis of S-(1,2 dichlorovinyl)-L-cysteine-induced cataractogenesis in vitro
90. Methimazole and generation of oxygen radicals by monocytes: Potential role in immunosuppression
91. Choanal atresia and hypothelia following methimazole exposure in utero: A second report
92. Propylthiouracil-induced cutaneous vasculitis
93. Flavin-containing monooxygenases: Enzymes adapted for multisubstrate specificity